Crossmark

BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway

Crossref DOI link: https://doi.org/10.1186/s12885-018-5027-9

Published Online: 2018-11-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Fenfen

Chen, Qin

Huang, Genping

Guo, Xuedong

Li, Na

Li, Yang

Li, Baohua http://orcid.org/0000-0002-2205-3248
Funding

Funding for this research was provided by:

Zhejiang Provincial Natural Science Foundation of China (LY18H160004)

the Medical and Health Science and Technology Plan Project of Zhejiang Province (2015KYA124)

the National Natural Science Foundation of China (81202066, 81672568)
License Information

Text and Data Mining valid from 2018-11-16
More Information

Article History

Received: 25 April 2018

Accepted: 31 October 2018

First Online: 16 November 2018

Ethics approval and consent to participate

: The present study was approved by the Institutional Review Board, Women’s hospital, School of Medicine, Zhejiang University. Written, informed consent has been given and obtained from all individual participants included in the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.